跳至主要内容
临床试验/NCT05814549
NCT05814549进行中(未招募)不适用

A Study of Using Plasma Circulating Cell Free Human Papillomavirus Deoxyribonucleic Acid to Screen (cf HPV DNA) for HPV-Related Oropharyngeal Cancer

Memorial Sloan Kettering Cancer Center7 个研究点 分布在 1 个国家目标入组 9 人开始时间: 2023年3月31日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
入组人数
9
试验地点
7
主要终点
Proportion of participants found to have HPV-related OPC

研究概览

简要总结

The researchers think that a blood test (NavDx®) may be able to identify cancer early by looking for circulating DNA from Human Papillomavirus/HPV. Circulating DNA are small pieces of genes that are released into the bloodstream. The purpose of this study is to find out whether using this blood test to test for HPV DNA will help detect HPV-related Oropharyngeal Cancer/OPC.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ages 45 and older
  • Self-reported history of four or more lifetime sexual partners
  • Self-reported history of one or more lifetime oral sexual partner
  • No previous history of diagnosed HPV-related head and neck cancer

排除标准

  • History of diagnosed HPV-related OPC
  • Less than three sexual partners in lifetime
  • No history of oral sex performed
  • Younger than age 45

结局指标

主要结局

Proportion of participants found to have HPV-related OPC

时间窗: Up to 5 years

: The primary objective is to determine the feasibility of screening by estimating the yield (proportion of subjects found to have HPV-related OPC out of all subjects screened).

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (7)

Loading locations...

相似试验